The use of antibiotics in young children is widespread and may lead to adverse effects on dental health, including staining, developmental defects, and dental caries.
To systematically review the effects of early childhood antibiotic exposure on dental health.
Medline (Ovid/PubMed), Embase (Ovid) and Cochrane databases. Study bias was assessed using the Newcastle-Ottawa Scale.
English language articles that reported antibiotic exposure before 8 years of age and 1 or more of the relevant outcomes (dental caries, intrinsic tooth staining, or developmental defects of enamel) were included.
Data on study population, design, type of antibiotic, outcome measurement, and results were extracted from the identified studies.
The initial search yielded 1003 articles of which 34 studies were included. Five of the 18 studies on tetracycline described a dose response relationship between exposure to tetracycline doses of > 20 mg/kg per day and dental staining. Early childhood exposure to doxycycline (at any dose) was not associated with dental staining. There was no clear association between any early childhood antibiotic exposure and dental caries or enamel defects.
In all included studies, the main limitations and sources of bias were the lack of comparison groups, inconsistent outcome measures, and lack of adjustment for relevant confounders.
There was no evidence that newer tetracycline formulations (doxycycline and minocycline) at currently recommended dosages led to adverse effects on dental health. Findings regarding antibiotic exposure and developmental defects of enamel or dental caries were inconsistent. Further prospective studies are warranted.
Antibiotics are the most commonly prescribed medications in childhood; in Australia their use has increased by 230% in the 10 years between 2000 and 2010.1 Antibiotics are suggested to have a myriad of effects on dental health, particularly tooth staining, developmental tooth defects (enamel hypoplasia and hypomineralization), and dental caries.2 However, data are inconsistent, with both adverse and protective effects reported.3–7
The mechanisms underlying these putative associations include direct effects on tooth development and indirect influences via the oral microbiome.2,8,9 Antibiotics can directly interfere with the highly sensitive process of tooth mineralization, leading to developmental dental defects such as enamel hypoplasia and hypomineralization.10 These defects present clinically as tooth discoloration and breakdown, often necessitating complex dental treatment.11–13 In addition, early life exposure to tetracycline antibiotics can lead to formation of complexes within the tooth structure, resulting in characteristic “tetracycline staining” with dark banding across the tooth.14–16 However, recent studies suggest that newer formulations of tetracycline antibiotics (e.g., doxycycline) may not cause tooth staining.17–19
Dental caries (tooth decay) affects 60% to 90% of children globally.20–22 Dental caries is a multifactorial disease that occurs as a result of oral microbial dysbiosis driven by dietary sugar and dental plaque. Antibiotic exposure may therefore potentially affect the pathogenesis of dental caries both directly (via the oral microbiome) and indirectly (via contributing to enamel defects).23 Early studies focused on the inverse relationship between antibiotic exposure and dental caries and subsequent findings indicate a possible relationship between antibiotic exposure and enamel defects.3,24–26 Data on newer antibiotic formulations and their association with dental caries and enamel defects are inconsistent.27,28
Therefore, we conducted a systematic review to evaluate the evidence regarding the effect of early childhood antibiotic exposure on dental caries, developmental defects of enamel, and tooth staining.
Methods
This study followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines (Supplemental Table 5). The review was registered in the PROSPERO database (CRD42020179098).
Medline (PubMed/Ovid), Embase (Ovid; 1946-current), and the Cochrane Library databases were searched in September 2021 using the search strategies listed in Supplemental Materials, Methods. All searches were limited to the English language. Reference lists of included articles were checked. In addition, Pro-Quest Dissertation Abstracts and Thesis database and Google Scholar were searched for gray literature.
Studies were included if they reported antibiotic exposure before 8 years of age (the period of tooth development) and 1 or more of the relevant outcomes (dental caries, intrinsic tooth staining, or developmental defects of enamel) based on visual assessment of the dentition. Developmental defects of enamel with a known etiology such as fluorosis and amelogenesis imperfecta were excluded as outcome measures.29 For the outcomes of dental caries and developmental defects of enamel, only studies using a validated index were included (Supplemental Table 6). As there is no validated tool to measure tetracycline staining, studies using any clearly described method were included.
Two independent investigators (D.R. and G.H.) assessed eligibility of all studies in Covidence (Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia), in a 2-stage screening process; by title and abstract and then by full text. Initial disagreements were resolved by discussion and then by a third independent reviewer (M.S.).
Data on study population, design, type of antibiotic, outcome measurement, and results were extracted from the identified studies by a sole investigator (D.R.) using a standardized extraction form. All data extraction was audited by a second reviewer (G.H.). Odds ratios (OR), P values, and 95% confidence intervals (CIs) were extracted from studies that quantified the risk of caries, developmental defects of enamel, and dental staining with the exposure to antibiotics. If not reported and when possible, the odds ratios and confidence intervals were calculated. All analyses were performed using Stata 16 software (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC). Because of heterogeneity and lack of data on covariates, meta-analysis was not considered appropriate.
The studies were assessed for risk of bias according to both the Newcastle Ottawa Scale and Risk Of Bias In Non-randomized Studies - of Exposure tool by a sole investigator (D.R.) (Supplemental Tables 7 and 8) and audited by a second reviewer (M.S.).30,31 The Newcastle Ottawa Scale was modified to suit the research question (Supplemental Table 9). No studies were excluded on the basis of the bias assessment.
Results
Study Characteristics
The initial search yielded 1003 articles with 756 articles screened by title and abstract after duplicates had been removed. Overall, 34 were found to be eligible for qualitative analysis (Fig 1). All 34 studies were retrospective cohort studies. A total of 18 studies investigated tetracyclines and/or tetracycline derived antibiotics, 7 investigated amoxicillin only, and 9 did not specify the antibiotic class.
The PRISMA flow diagram details the search and selection process undertaken during the review.
The PRISMA flow diagram details the search and selection process undertaken during the review.
Exposure ascertainment was based on hospital and pharmacy records or patient and parent recall of medication use. The median age at the time of antibiotic exposure was 6 years (range 0–8 years). Outcomes were measured between 24 months to 18 years of age. Sample size varied from 25 to 29 485 participants (Table 1).3,32
Study Characteristics and Risk of Bias for Included Studies
Study Descriptors . | Antibiotic . | Outcome Measures . | Newcastle-Ottawa Bias Analysis . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journal Article . | Level of Evidence . | Number of Subjects . | Subject Characteristics . | Study Design . | Type of Antibiotic . | Dosage . | Length of Medication . | Caries . | Dental Staining . | Developmental Defects of Enamel . | Selection . | Comparability . | Outcomes . |
Ahmadi, 201251 | Cohort study | 433 | 7–9-y old’s | Cross-sectional study | Amoxicillin | Unknown | Unknown | DMFT | — | DDE index | 4 | — | 3 |
Alaki, 20093 | Cohort study | 29 485 | 13–24 mo | Cross-sectional study | Penicillin | Unknown | Unknown | ECC - restoration, SCC, sedative filling, pulp treatment or extraction of primary dentition SECC - any smooth surface caries less than 3 y | — | — | 3 | — | 4 |
Allazzam, 201457 | Cohort study | 267 | 8–12-y old’s | Cross-sectional study | Not specified | Unknown | Unknown | — | EAPD Judgement for MIH | 3 | — | 3 | |
Arrow, 200957 | Cohort study | 550 | 5–6-y old’s | Cross-sectional study | Medication; amoxicillin; other medication; other antibiotic | Unknown | Unknown | WHO criteria | — | Modified DDE Index | 3 | 1 | 3 |
Brearley, 197338 | Cohort study | 100 | 3–12-y old’s | Cross-sectional study | Tetracycline | Unknown | Unknown | DMFT | Dental Staining as the following criteria - pale yellow, bright yellow, brown, or gray-brown, yellow-brown, gray, gray-yellow, or orange | — | 1 | 1 | 3 |
Cascio, 200450 | Cohort study | 41 | 10.1 to 13 y | Cross-sectional study | Minocycline | 5 mg/kg per day | 21 d | — | — | Developmental Defects of Enamel Index | 3 | 1 | 3 |
Conchie, 197041 | Cohort study | 238 | 8 to 11 y | Cross-sectional study | Tetracycline | 26.7 mg/kg per day | 11 d | — | Staining via fluorescence | — | 4 | — | 3 |
Frankel, 196446 | Cohort study | 25 | 4 to 55 d | Retrospective cohort | Doxycycline | 2 mg/kg on first day and then 1 mg/kg every day after | 6 to 17 d | — | Fluorescence | — | 3 | — | 3 |
Forti, 196932 | Cohort study | 1724 | 5 to 10 y | Cross-sectional study | Tetracycline | 20 mg/kg per day | Unknown | — | Staining as colors and fluorescence | — | 1 | 1 | 4 |
Giuca, 201852 | Cohort study | 120 | 9.8 ± 1.8 y; 10.2 ± 2 y | Cross-sectional study | Antibiotics | Unknown | Unknown | — | — | Weerheijm (MIH Index) | 3 | 1 | 3 |
Grossman, 197142 | Cohort study | 160 | 6 to 12 y | Cross-sectional study | Demethylchlortetracycline tetracycline | 20 mg/kg per day | 6 d | — | Staining against tooth shade guide and under UV light | — | 3 | — | 3 |
Hamp, 196743 | Cohort study | 40 | — | Cross-sectional study | Tetracycline | 20 mg/kg per day | 7 d | Caries presence | Color | Hypoplasia | 1 | — | 1 |
Handelman, 196655 | Cohort study | 393 | 6 to 19 y | Cross-sectional study | 2 groups: penicillin and penicillin + tetracycline | 5 mg/kg per day to 29 mg/kg per day | 2.5 y | Ability to be able to penetrate the surface with an explorer and evidence of deterioration of enamel walls or softened cavity floor | — | — | 4 | — | 3 |
Hysi, 201658 | Cohort study | 1575 | 8–10 y | Cross-sectional study | Not specified | Unknown | Unknown | — | — | MIH - Weerheijm | 3 | — | 3 |
Jälevik, 200164 | Cohort Study | 516 | 8-y old’s | Cross-sectional study | Not specified | Unknown | Unknown | — | — | Modified DDE Index | 3 | 1 | 3 |
Kinirons, 19922 | Cohort study | 164 | 4 to 18 y | Cross-sectional study | Not specified | Unknown | Unknown | DMFT | — | — | 1 | 1 | 4 |
Lahdesmaki, 201648 | Cohort study | 39 | 13.5 y average | Retrospective cohort | Doxycycline | 6.25 mg/kg per day | 12 d | — | Not specified | — | 1 | — | 3 |
Laisi, 200953 | Cohort study | 141 | 10.7 y average with SD 1.3 and range from 7.8–12.7 y | Cross-sectional study | Penicillin V amoxicillin | Unknown | Unknown | — | — | Developmental Defects of Enamel Index | 3 | — | 3 |
Littleton, 196454 | Cohort study | 435 | 6 to 13 y | Cross-sectional study | Penicillin | 200 000 U per day | Unknown | DMF Index | — | — | 4 | — | 3 |
Lochary, 199849 | Cohort study | Mean age of 13.7 y with 11 to 19 y | Retrospective cohort | Doxycycline | Range from 25 mg/kg to 100 mg/kga | Range from 1 to 10 d | — | Ordinal number scale; researchers own method | — | 4 | — | 3 | |
Mariri, 200360 | Cohort study | 39 | 4–7 y | Case-control | Antibiotics | Unknown | Unknown | Pitts et al criteria | — | — | 3 | 1 | 3 |
Martin, 196939 | Cohort study | 4690 | 4 to 17 y | Retrospective cohort | Tetracycline | Unknown | Unknown | — | Researchers own method | Barnard Index 1967 | 3 | — | 3 |
Pöyhönen, 201747 | Cohort study | 38 | 4.7 average; 0.6 to 7.9 y | Retrospective cohort | Doxycycline | 6.25 mg/kg per day | 12.5 d | — | Diffuse discolored bands of tooth crown | Enamel hypoplasia | 4 | — | 3 |
Primosch, 198040 | Cohort study | 86 | 3 to 24 y | Retrospective cohort | Tetracycline | Unknown | Unknown | Clinical and radiographic criteria from Davies and Cadell | Discoloration | Weinmann And Associates Criteria | 4 | 1 | 4 |
Souza, 201263 | Cohort study | 903 | 6–12 y old | Cross sectional study | Antibiotics | Unknown | Unknown | — | — | EAPD MIH Judgement | 4 | — | 1 |
Swallow, 196744 | Cohort study | 63 | 1–15 y | Retrospective cohort | Tetracycline, oxytetracycline, chlortetracycline | 20 mg/kg per day | Unknown | — | Authors own severity index - compared with 30 artificial teeth | — | 4 | — | 3 |
Tariq, 20149 | Cohort study | 367 | 7–14 y | Cross-sectional study | Penicillin, cephalosporin | Unknown | Unknown | — | — | DDE Index | 3 | — | 3 |
Todd, 201517 | Cohort study | 58 | 8 to 16 y | Cross-sectional study | Doxycycline | 2.3 mg/kg per day | 7.3 d | — | Own methods assessed against a spectrophotometer | — | 3 | 1 | 3 |
Volovitz, 200719 | Cohort study | 61 | 10.4 ± 2.1 y | Cross sectional study | Doxycycline | 4 mg/kg per day | 11 d | — | Measured against a shade guide | — | 4 | — | 3 |
Wallman, 196245 | Cohort study | 67 | Premature babies | Cross sectional study | Oxytetracycline tetracycline | 38 mg/kg per day | 5 d | — | Not mentioned | — | 3 | — | 4 |
Weyman, 196674 | Cohort study | 41 | — | Case-control | Tetracycline | Unknown | Unknown | DMF Index | — | — | 4 | — | 3 |
Whatling, 200861 | Cohort study | 109 | 8.7 y (6–13 y) | Cross-sectional study | Mixed, penicillin, amoxicillin, erythromycin, trimethoprim | 10 mg/kg per day | Unknown | — | — | Not specified | 4 | — | 3 |
Wuollet, 201662 | Cohort study | 287 | 7–12 y | Retrospective cohort | Penicillin amoxicillin cephalosporin sulphonamide-trimethoprim macrolide | Unknown | Unknown | — | — | EAPD MIH Judgement | 4 | 4 | 4 |
Zegarelli, 196675 | Cohort study | 28 | 6 to 8 y | Retrospective cohort | Oxytetracycline | 10 mg/kg per day | 5 d | — | Mean intensity, visual examination | — | 3 | — | 1 |
Study Descriptors . | Antibiotic . | Outcome Measures . | Newcastle-Ottawa Bias Analysis . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journal Article . | Level of Evidence . | Number of Subjects . | Subject Characteristics . | Study Design . | Type of Antibiotic . | Dosage . | Length of Medication . | Caries . | Dental Staining . | Developmental Defects of Enamel . | Selection . | Comparability . | Outcomes . |
Ahmadi, 201251 | Cohort study | 433 | 7–9-y old’s | Cross-sectional study | Amoxicillin | Unknown | Unknown | DMFT | — | DDE index | 4 | — | 3 |
Alaki, 20093 | Cohort study | 29 485 | 13–24 mo | Cross-sectional study | Penicillin | Unknown | Unknown | ECC - restoration, SCC, sedative filling, pulp treatment or extraction of primary dentition SECC - any smooth surface caries less than 3 y | — | — | 3 | — | 4 |
Allazzam, 201457 | Cohort study | 267 | 8–12-y old’s | Cross-sectional study | Not specified | Unknown | Unknown | — | EAPD Judgement for MIH | 3 | — | 3 | |
Arrow, 200957 | Cohort study | 550 | 5–6-y old’s | Cross-sectional study | Medication; amoxicillin; other medication; other antibiotic | Unknown | Unknown | WHO criteria | — | Modified DDE Index | 3 | 1 | 3 |
Brearley, 197338 | Cohort study | 100 | 3–12-y old’s | Cross-sectional study | Tetracycline | Unknown | Unknown | DMFT | Dental Staining as the following criteria - pale yellow, bright yellow, brown, or gray-brown, yellow-brown, gray, gray-yellow, or orange | — | 1 | 1 | 3 |
Cascio, 200450 | Cohort study | 41 | 10.1 to 13 y | Cross-sectional study | Minocycline | 5 mg/kg per day | 21 d | — | — | Developmental Defects of Enamel Index | 3 | 1 | 3 |
Conchie, 197041 | Cohort study | 238 | 8 to 11 y | Cross-sectional study | Tetracycline | 26.7 mg/kg per day | 11 d | — | Staining via fluorescence | — | 4 | — | 3 |
Frankel, 196446 | Cohort study | 25 | 4 to 55 d | Retrospective cohort | Doxycycline | 2 mg/kg on first day and then 1 mg/kg every day after | 6 to 17 d | — | Fluorescence | — | 3 | — | 3 |
Forti, 196932 | Cohort study | 1724 | 5 to 10 y | Cross-sectional study | Tetracycline | 20 mg/kg per day | Unknown | — | Staining as colors and fluorescence | — | 1 | 1 | 4 |
Giuca, 201852 | Cohort study | 120 | 9.8 ± 1.8 y; 10.2 ± 2 y | Cross-sectional study | Antibiotics | Unknown | Unknown | — | — | Weerheijm (MIH Index) | 3 | 1 | 3 |
Grossman, 197142 | Cohort study | 160 | 6 to 12 y | Cross-sectional study | Demethylchlortetracycline tetracycline | 20 mg/kg per day | 6 d | — | Staining against tooth shade guide and under UV light | — | 3 | — | 3 |
Hamp, 196743 | Cohort study | 40 | — | Cross-sectional study | Tetracycline | 20 mg/kg per day | 7 d | Caries presence | Color | Hypoplasia | 1 | — | 1 |
Handelman, 196655 | Cohort study | 393 | 6 to 19 y | Cross-sectional study | 2 groups: penicillin and penicillin + tetracycline | 5 mg/kg per day to 29 mg/kg per day | 2.5 y | Ability to be able to penetrate the surface with an explorer and evidence of deterioration of enamel walls or softened cavity floor | — | — | 4 | — | 3 |
Hysi, 201658 | Cohort study | 1575 | 8–10 y | Cross-sectional study | Not specified | Unknown | Unknown | — | — | MIH - Weerheijm | 3 | — | 3 |
Jälevik, 200164 | Cohort Study | 516 | 8-y old’s | Cross-sectional study | Not specified | Unknown | Unknown | — | — | Modified DDE Index | 3 | 1 | 3 |
Kinirons, 19922 | Cohort study | 164 | 4 to 18 y | Cross-sectional study | Not specified | Unknown | Unknown | DMFT | — | — | 1 | 1 | 4 |
Lahdesmaki, 201648 | Cohort study | 39 | 13.5 y average | Retrospective cohort | Doxycycline | 6.25 mg/kg per day | 12 d | — | Not specified | — | 1 | — | 3 |
Laisi, 200953 | Cohort study | 141 | 10.7 y average with SD 1.3 and range from 7.8–12.7 y | Cross-sectional study | Penicillin V amoxicillin | Unknown | Unknown | — | — | Developmental Defects of Enamel Index | 3 | — | 3 |
Littleton, 196454 | Cohort study | 435 | 6 to 13 y | Cross-sectional study | Penicillin | 200 000 U per day | Unknown | DMF Index | — | — | 4 | — | 3 |
Lochary, 199849 | Cohort study | Mean age of 13.7 y with 11 to 19 y | Retrospective cohort | Doxycycline | Range from 25 mg/kg to 100 mg/kga | Range from 1 to 10 d | — | Ordinal number scale; researchers own method | — | 4 | — | 3 | |
Mariri, 200360 | Cohort study | 39 | 4–7 y | Case-control | Antibiotics | Unknown | Unknown | Pitts et al criteria | — | — | 3 | 1 | 3 |
Martin, 196939 | Cohort study | 4690 | 4 to 17 y | Retrospective cohort | Tetracycline | Unknown | Unknown | — | Researchers own method | Barnard Index 1967 | 3 | — | 3 |
Pöyhönen, 201747 | Cohort study | 38 | 4.7 average; 0.6 to 7.9 y | Retrospective cohort | Doxycycline | 6.25 mg/kg per day | 12.5 d | — | Diffuse discolored bands of tooth crown | Enamel hypoplasia | 4 | — | 3 |
Primosch, 198040 | Cohort study | 86 | 3 to 24 y | Retrospective cohort | Tetracycline | Unknown | Unknown | Clinical and radiographic criteria from Davies and Cadell | Discoloration | Weinmann And Associates Criteria | 4 | 1 | 4 |
Souza, 201263 | Cohort study | 903 | 6–12 y old | Cross sectional study | Antibiotics | Unknown | Unknown | — | — | EAPD MIH Judgement | 4 | — | 1 |
Swallow, 196744 | Cohort study | 63 | 1–15 y | Retrospective cohort | Tetracycline, oxytetracycline, chlortetracycline | 20 mg/kg per day | Unknown | — | Authors own severity index - compared with 30 artificial teeth | — | 4 | — | 3 |
Tariq, 20149 | Cohort study | 367 | 7–14 y | Cross-sectional study | Penicillin, cephalosporin | Unknown | Unknown | — | — | DDE Index | 3 | — | 3 |
Todd, 201517 | Cohort study | 58 | 8 to 16 y | Cross-sectional study | Doxycycline | 2.3 mg/kg per day | 7.3 d | — | Own methods assessed against a spectrophotometer | — | 3 | 1 | 3 |
Volovitz, 200719 | Cohort study | 61 | 10.4 ± 2.1 y | Cross sectional study | Doxycycline | 4 mg/kg per day | 11 d | — | Measured against a shade guide | — | 4 | — | 3 |
Wallman, 196245 | Cohort study | 67 | Premature babies | Cross sectional study | Oxytetracycline tetracycline | 38 mg/kg per day | 5 d | — | Not mentioned | — | 3 | — | 4 |
Weyman, 196674 | Cohort study | 41 | — | Case-control | Tetracycline | Unknown | Unknown | DMF Index | — | — | 4 | — | 3 |
Whatling, 200861 | Cohort study | 109 | 8.7 y (6–13 y) | Cross-sectional study | Mixed, penicillin, amoxicillin, erythromycin, trimethoprim | 10 mg/kg per day | Unknown | — | — | Not specified | 4 | — | 3 |
Wuollet, 201662 | Cohort study | 287 | 7–12 y | Retrospective cohort | Penicillin amoxicillin cephalosporin sulphonamide-trimethoprim macrolide | Unknown | Unknown | — | — | EAPD MIH Judgement | 4 | 4 | 4 |
Zegarelli, 196675 | Cohort study | 28 | 6 to 8 y | Retrospective cohort | Oxytetracycline | 10 mg/kg per day | 5 d | — | Mean intensity, visual examination | — | 3 | — | 1 |
DMFT, mean number of decayed, missing or filled teeth; EAPD, European Association of Paediatric Dentistry; ECC, early childhood caries; SCC, severe childhood caries; SECC, severe early childhood caries; —, Not Applicable.
The antibiotic dose for each patient was not given and no length of administration so unable to convert dosage to mg/kg per day.
The methods used to measure and quantify the 3 outcomes (dental caries, enamel defects, and dental staining) varied considerably. A total of 3 different measures were used for caries, 10 for dental staining, and 7 for enamel defects (Supplemental Table 6).33–35 In addition to detection of tetracycline staining from visual and laboratory analyses, general intrinsic staining was determined by measuring tooth color using a shade guide or spectrometer and applying an arbitrary threshold. The 7 indices used to measure developmental defects of enamel were variations of 2 core validated indices (European Academy of Pediatric Dentistry Criteria for molar-incisor hypomineralization [MIH] and Developmental Defects of Enamel [DDE] Index) (Supplemental Table 6).36,37
Tetracycline and Tetracycline Derived Antibiotics
Tetracycline and Intrinsic Staining
Eighteen studies investigated tetracyclines and tetracycline derived antibiotics, most of which (n = 16) included dental staining as an outcome. Eleven studies investigated older formulations (e.g., tetracyclines), often at relatively higher doses (from 10 to 38 mg/kg per day), whereas 5 studies investigated the newer formulations (e.g., doxycycline), often at lower dosages (from 2.3 to 6.25 mg/kg per day) (Table 2). Dosage was not reported in 3 studies.38–40
Exposure to Tetracycline Antibiotics in Early Childhood and Reported Effects on Later Dental Health
Article . | Antibiotic . | Outcome Measure . | Dosage (mean) . | Duration (mean) . | Results OR (95% CI)a . | RoB . |
---|---|---|---|---|---|---|
Brearley, 197338 | Tetracycline | Tooth staining | Unknown | Unknown | 19/100 with staining | Serious |
Conchie, 197041 | Tetracycline | Tooth staining | 26.7 mg/kg per day | 11 d | 11.62 (5.96–24.32) | Moderate |
Frankel, 196446 | Tetracycline | Tooth staining | 20 mg/kg per day | 0.49 (0.02–0.27) | Critical | |
Grossman, 197142 | Tetracycline, demethylchlortetracycline | Tooth staining | 20 mg/kg per day | 6 d | Meanc of affected group: 2.57 (−1 to 8); mean of unaffected group: 0.86 (−1 to 6.5); | Moderate |
Hamp, 196743 | Tetracycline | Tooth staining | 20 mg/kg per day | 7 d | 20.25 (1.55–983.05) | Critical |
Lahdesmaki, 201648 | Doxycycline | Tooth staining | 6.25 mg/kg per day | 12 d | 0.03 (0.01–0.76) | Serious |
Lochary, 199849 | Doxycycline | Tooth staining | Range from 25 mg/kg to 100 mg/kg | Range from 1 to 10 d | P = .38 | Moderate |
Martin, 196939 | Tetracycline | Tooth staining | 145.18 (58.79–358.54) | Serious | ||
Pöyhönen, 201747 | Doxycycline | Tooth staining | 6.25 mg/kg per day | 12.5 d | 0.03 (0.01–0.78) | Moderate |
Swallow, 196744 | Tetracycline | Tooth staining | 20 mg/kg per day | 5.77 (0.73–260.60) | Serious | |
Todd, 200717 | Doxycycline | Tooth staining | 2.3 mg/kg per day | 7.3 d | No patients with staining | Low |
Volovitz, 200719 | Doxycycline | Tooth staining | 4 mg/kg per day | 11 d | 0.99 (0.01–78.46) | Moderate |
Wallman, 196245 | Tetracycline | Tooth Staining | 38 mg/kg per day | 5 d | 231.00 (19.34–2759.99) | Critical |
Zegarelli, 196675 | Oxytetracycline | Tooth staining | 10 mg/kg per day | 5 d | 2.11 (0.02–174.27) | Serious |
Forti, 196932 | Tetracycline | Tooth staining | 1st dose: 2 mg/kg per day second day: 1 mg/kg per day | 6 to 17 d | No patients with staining | Critical |
Primosch, 198040 | Tetracycline | Tooth staining | Unknown | Unknown | 21/86 discoloration | Moderate |
Cascio, 200450 | Minocycline | DDE | 5 mg/kg per day | 21 d | 0.90 (0.38–2.11) | Serious |
Grossman, 197142 | Tetracycline, demethylchlortetracycline | Hypoplasia | 20 mg/kg per day | NA | No patients with hypoplasia | Moderate |
Hamp, 196743 | Tetracycline | Hypoplasia | 20 mg/kg per day | NA | 5.83 (0.42–314.48) | Critical |
Todd, 200717 | Doxycycline | Hypoplasia | 2.3 mg/kg per day | NA | 0.92 (0.2–4.2) | Low |
Primosch, 198040 | Tetracycline | Enamel defects | Unknown | Unknown | 21/86 enamel defects | Moderate |
Brearley, 197338 | Tetracycline | DMFT | Unknown | Unknown | P < .01b | Serious |
Swallow, 196744 | Tetracycline | DMFT | 20 mg/kg per day | Unknown | 1.42 (0.34–7.06) | Serious |
Weyman, 196674 | Tetracycline | DMFT | 38 mg/kg per day | Unknown | 29/41 had caries | Critical |
Primosch, 198040 | Tetracycline | DMFT | Unknown | Unknown | Mean carious surfaces of exposed group 7.5 ± 1.0; mean of unexposed group 13.5 ± 1.3 | Moderate |
Article . | Antibiotic . | Outcome Measure . | Dosage (mean) . | Duration (mean) . | Results OR (95% CI)a . | RoB . |
---|---|---|---|---|---|---|
Brearley, 197338 | Tetracycline | Tooth staining | Unknown | Unknown | 19/100 with staining | Serious |
Conchie, 197041 | Tetracycline | Tooth staining | 26.7 mg/kg per day | 11 d | 11.62 (5.96–24.32) | Moderate |
Frankel, 196446 | Tetracycline | Tooth staining | 20 mg/kg per day | 0.49 (0.02–0.27) | Critical | |
Grossman, 197142 | Tetracycline, demethylchlortetracycline | Tooth staining | 20 mg/kg per day | 6 d | Meanc of affected group: 2.57 (−1 to 8); mean of unaffected group: 0.86 (−1 to 6.5); | Moderate |
Hamp, 196743 | Tetracycline | Tooth staining | 20 mg/kg per day | 7 d | 20.25 (1.55–983.05) | Critical |
Lahdesmaki, 201648 | Doxycycline | Tooth staining | 6.25 mg/kg per day | 12 d | 0.03 (0.01–0.76) | Serious |
Lochary, 199849 | Doxycycline | Tooth staining | Range from 25 mg/kg to 100 mg/kg | Range from 1 to 10 d | P = .38 | Moderate |
Martin, 196939 | Tetracycline | Tooth staining | 145.18 (58.79–358.54) | Serious | ||
Pöyhönen, 201747 | Doxycycline | Tooth staining | 6.25 mg/kg per day | 12.5 d | 0.03 (0.01–0.78) | Moderate |
Swallow, 196744 | Tetracycline | Tooth staining | 20 mg/kg per day | 5.77 (0.73–260.60) | Serious | |
Todd, 200717 | Doxycycline | Tooth staining | 2.3 mg/kg per day | 7.3 d | No patients with staining | Low |
Volovitz, 200719 | Doxycycline | Tooth staining | 4 mg/kg per day | 11 d | 0.99 (0.01–78.46) | Moderate |
Wallman, 196245 | Tetracycline | Tooth Staining | 38 mg/kg per day | 5 d | 231.00 (19.34–2759.99) | Critical |
Zegarelli, 196675 | Oxytetracycline | Tooth staining | 10 mg/kg per day | 5 d | 2.11 (0.02–174.27) | Serious |
Forti, 196932 | Tetracycline | Tooth staining | 1st dose: 2 mg/kg per day second day: 1 mg/kg per day | 6 to 17 d | No patients with staining | Critical |
Primosch, 198040 | Tetracycline | Tooth staining | Unknown | Unknown | 21/86 discoloration | Moderate |
Cascio, 200450 | Minocycline | DDE | 5 mg/kg per day | 21 d | 0.90 (0.38–2.11) | Serious |
Grossman, 197142 | Tetracycline, demethylchlortetracycline | Hypoplasia | 20 mg/kg per day | NA | No patients with hypoplasia | Moderate |
Hamp, 196743 | Tetracycline | Hypoplasia | 20 mg/kg per day | NA | 5.83 (0.42–314.48) | Critical |
Todd, 200717 | Doxycycline | Hypoplasia | 2.3 mg/kg per day | NA | 0.92 (0.2–4.2) | Low |
Primosch, 198040 | Tetracycline | Enamel defects | Unknown | Unknown | 21/86 enamel defects | Moderate |
Brearley, 197338 | Tetracycline | DMFT | Unknown | Unknown | P < .01b | Serious |
Swallow, 196744 | Tetracycline | DMFT | 20 mg/kg per day | Unknown | 1.42 (0.34–7.06) | Serious |
Weyman, 196674 | Tetracycline | DMFT | 38 mg/kg per day | Unknown | 29/41 had caries | Critical |
Primosch, 198040 | Tetracycline | DMFT | Unknown | Unknown | Mean carious surfaces of exposed group 7.5 ± 1.0; mean of unexposed group 13.5 ± 1.3 | Moderate |
DMFT, mean number of decayed, missing or filled teeth; ECC, early childhood caries; NA, not applicable; RoB, risk of bias; Ab, antibiotic.
Where possible odds ratios of the likelihood of having the outcome measure were calculated and presented with 95% confidence interval. In some cases, the mean value of the exposed group compared with the control groups is given with respect to that outcome measure. If no comparison group was present, the number of the exposed group with the outcome is given as a nominal value over the entire exposed population.
Only a P value was reported.
Mean refers to average color of teeth.
Three studies assessed the presence of the characteristic pattern of tetracycline staining from visual inspection and 4 studies used fluorescence of exfoliated or extracted teeth. Four studies used tooth color and shade as a marker of tetracycline staining. The 5 remaining studies used a combination of the above methods or study specific outcome measures based on inherent tooth shade (intrinsic staining).
The studies investigating older formulations of tetracyclines were published between 1962 and 1980 and had a moderate to critical risk of bias, often failing to clearly report the method for measurement of outcomes. Higher doses of tetracyclines were associated with increased presence of dental staining. In 5 studies, doses of ≥20 mg/kg per day with a duration from 5 to 11 days were associated with dental staining, whereas only 1 study of the same dose reported no association.41–46 The study that reported the strongest association (OR: 11.62, 95% CI 5.96–24.32) evaluated the highest dose for the longest consecutive duration (26.7 mg/kg per day for a mean of 11 days).41
All 5 studies evaluating the relationship between newer formulations of tetracycline (minocycline and doxycycline) and dental staining showed no association. The studies were published between 1998 to 2017 and average dosage ranged from 2.3 to 25 mg/kg per day with a mean duration of 10.7 days.17,19,47–49 Notably, no cases of tetracycline staining were observed in 58 and 78 children at average doses of 2.3 mg/kg per day and 6.25 mg/kg per day, respectively. Although the overall risk of bias varied, there was evidence from 3 low bias studies that doxycycline did not cause intrinsic staining, including tetracycline staining.17,19,47
Developmental Defects of Enamel
Five studies investigated the relationship between childhood use of tetracycline derived antibiotics and developmental defects of enamel.17,40,42,43,50 Four of these papers provided details regarding dosage (Table 2). Two papers reported contradictory results for tetracycline at doses of 20 mg/kg per day.42,43 One study with a critical level of bias investigated 40 premature infants with an average treatment duration of 4 days and found higher odds of enamel defects (OR 5.83, 95% CI 0.42–314.48). However, the study did not address the role of prematurity on the relationship.43 In contrast, the other study with a moderate level of bias investigated 160 participants aged 6 to 12 years with an average of 6 days of medication and found no cases of enamel hypoplasia.42
The 2 studies of newer formulations (doxycycline at 5 mg/kg per day and minocycline at 2.3 mg/kg per day) did not report an increased odds of enamel hypoplasia (OR 0.89, 95% CI 0.38–2.11; OR 0.92, 95% CI 0.2–4.2).17,50 The findings from these 5 studies are contradictory and preclude clear conclusions but suggest that newer formulations at lower dosages likely do not have an association with developmental defects of enamel.17,40,42,43,50
Dental Caries
Three of the 4 studies of dental caries used the total number of decayed, missing, filled teeth, or surfaces based on visual inspection as a measure of caries prevalence or severity; a single study used radiographic evaluation in addition to a clinical criterion. Tetracycline use at 20 mg/kg per day had no association with the presence of dental caries (OR 1.42, 95% CI 0.34–7.06).44 A study of 100 participants found fewer carious tooth surfaces (0.099 ± 0.088) in the exposed group compared with the comparison group (0.146 ± 0.087), however, this study had a serious level of bias because of a lack of confirmation of exposure.38 A similar association was also reported in a study of 86 patients who found a mean of 7.5 (±1.0) carious surfaces in the exposed group compared to a mean of 13.5 (±1.3) in the comparison group.40 All 4 studies had high levels of bias, with 1 lacking a comparator group and another reliant upon parent recall for exposure ascertainment and all failing to adjust for confounders, such as socioeconomic status (a major social determinant of dental caries risk).
Amoxicillin
Seven of the included studies evaluated the effect of amoxicillin on enamel defects and/or dental caries, whereas effects on intrinsic staining were not evaluated (Table 3).
Exposure to Amoxicillin in Early Childhood and Reported Effects on Dental Health
Article . | Antibiotic . | Outcome Measures . | Dosage (mean) . | Duration (mean) . | Results (OR, 95% CI)a . | RoB . |
---|---|---|---|---|---|---|
Ahmadi, 201251 | Amoxicillin | DMFT | Unknown | Unknown | Mean of affected group: 1.46 (SD: 0.99); mean of unaffected group: 0.76 (SD: 1.33) | Moderate |
Alaki, 20093 | Penicillin | ECC | Unknown | Unknown | Ab at 13–18 mo; P < .0001b Ab at 19–24 mo: P = .51b | Moderate |
Handelman, 196655 | Penicillin | DMFT | Range from 5 mg/kg per day to 29 mg/kg per day | 2.5 y | P = .004b | Moderate |
Littleton, 196454 | Penicillin | DMFT | 200 000 U of penicillin daily | Unknown | Mean of affected group: 3.55 (± 0.58); mean of unaffected group: 4.84 (± 0.32) | Moderate |
Ahmadi, 201251 | Amoxicillin | DDE | Unknown | Unknown | 7.87 (2.43–25.12) | Moderate |
Giuca, 201852 | Penicillin | DDE | Unknown | Unknown | 0.07 (0.02–0.27) | Moderate |
Laisi, 200953 | Penicillin | DDE | Unknown | Unknown | 4.14 (1.05–16.4) | Moderate |
Tariq, 20149 | Penicillin | DDE | Unknown | Unknown | 0.44 (0.25–0.77) | Low |
Article . | Antibiotic . | Outcome Measures . | Dosage (mean) . | Duration (mean) . | Results (OR, 95% CI)a . | RoB . |
---|---|---|---|---|---|---|
Ahmadi, 201251 | Amoxicillin | DMFT | Unknown | Unknown | Mean of affected group: 1.46 (SD: 0.99); mean of unaffected group: 0.76 (SD: 1.33) | Moderate |
Alaki, 20093 | Penicillin | ECC | Unknown | Unknown | Ab at 13–18 mo; P < .0001b Ab at 19–24 mo: P = .51b | Moderate |
Handelman, 196655 | Penicillin | DMFT | Range from 5 mg/kg per day to 29 mg/kg per day | 2.5 y | P = .004b | Moderate |
Littleton, 196454 | Penicillin | DMFT | 200 000 U of penicillin daily | Unknown | Mean of affected group: 3.55 (± 0.58); mean of unaffected group: 4.84 (± 0.32) | Moderate |
Ahmadi, 201251 | Amoxicillin | DDE | Unknown | Unknown | 7.87 (2.43–25.12) | Moderate |
Giuca, 201852 | Penicillin | DDE | Unknown | Unknown | 0.07 (0.02–0.27) | Moderate |
Laisi, 200953 | Penicillin | DDE | Unknown | Unknown | 4.14 (1.05–16.4) | Moderate |
Tariq, 20149 | Penicillin | DDE | Unknown | Unknown | 0.44 (0.25–0.77) | Low |
DMFT, mean number of decayed, missing or filled teeth; ECC, early childhood caries; NA, not applicable; RoB, risk of bias; Ab, antibiotic.
Where possible, odds ratios of the likelihood of having the outcome measure were calculated and presented with 95% confidence interval. In some cases, the mean value of the exposed group compared with the control groups is given with respect to that outcome measure. If no comparison group was present, the number of the exposed group with the outcome is given as a nominal value over the entire exposed population.
Only a P value was reported.
Developmental Defects of Enamel
Four studies investigated the relationship between amoxicillin and developmental defects of enamel.9,51–53 One study found a positive association (OR 7.88, 95% CI 2.43–25.12) between penicillin and developmental defects of enamel in a cohort of 433 with a median age of 7.8 years.51 This study had a low level of bias and adjusted for relevant confounders, such as fluoride exposure, tooth wear, and age. Conversely 2 studies with a low to moderate risk of bias in populations of 120 and 367 showed a protective association between penicillin (dosage not reported) and developmental defects of enamel with ORs 0.44 (95% CI 0.25–0.77) and 0.07 (95% CI 0.02–0.28).9,52
Dental Caries
There were 4 studies that investigated the relationship between amoxicillin and dental caries, all with a moderate level of bias.3,51,54,55 Only 2 studies reported dosage, with 1 being an average of 16 mg/kg per day and the other of 125 mg per day.54,55 One study with an exposure group of 433 in a population of 7 to 9 year olds found a higher number of carious surfaces in the exposed group (mean 1.46, SD: 0.99) than in the comparison group (0.76, SD: 1.33).51 Contrastingly, another study of penicillin (125 mg per day) found a lower number of carious surfaces in the exposed group of 6 to 13 year olds (mean 3.55, SD: 0.58) compared with the control group (mean 4.84, SD: 0.32).54 A birth cohort study of 29 485 participants found that the number of teeth affected by caries at 2 years of age was on average lower in children who had taken amoxicillin (P < .0001). However, dosage was not provided and odds ratios were unable to be calculated from the data provided, limiting conclusions about effect size.3 This was consistent with a cohort study of 393 participants where amoxycillin doses of 5 to 29 mg/kg per day were found to be protective for dental caries with a mean 0.47 (±0.6) carious surfaces in the exposed group, compared with 1.50 (±0.32) in the comparison group.55 Overall, a clear association could not be identified because of the heterogeneity in outcome measures across the studies.
Unspecified Classes of Antibiotics
Nine studies (Table 4) evaluated the dental effects of any antibiotic exposure by either combining several antibiotics into a single exposure group, or without specifying the antibiotic formulations.2,56–63 Out of 4 studies with low to moderate bias focused on MIH, a common developmental defect, 3 found a positive association with MIH prevalence. In contrast, none of the 3 studies with low to moderate risk of bias that investigated developmental defects of enamel in general (as opposed to MIH specifically) reported an association.57,61,64
Results for Unspecified Class of Antibiotics
Article . | Dosage . | Days . | Outcome Measures . | Resultsa . | RoB . |
---|---|---|---|---|---|
Allazzam, 201456 | Unknown | Unknown | EAPD for Judgement MIH | 4.822 (1.196–16.588) | Low |
Arrow, 200957 | Unknown | Unknown | DDE | 0.761 (0.462–1.271) | Low |
Hysi, 201658 | Unknown | Unknown | MIH | 1.41 (1.06–1.87) | Low |
Jälevik, 200164 | Unknown | Unknown | Modified DDE | 0.835 (0.640–1.867) | Low |
Whatling, 200861 | 10 mg/kg per day | NA | DDE | 0.61 (0.17–2.22) | Low |
Wuollet, 201662 | Unknown | Unknown | MIH | 1.72 (0.83–3.58) | Low |
Souza, 201263 | Unknown | Unknown | MIH | 0.93 (0.63–1.37) | Moderate |
Kinirons, 19922 | Unknown | Unknown | DMFT | Mean difference: 1.3 (±1.74); study group: 3.5 (±2.46); intervention group: 4.8 (±3.39) | Serious |
Mariri, 200360 | Unknown | Unknown | Caries | P = .057b | Low |
Article . | Dosage . | Days . | Outcome Measures . | Resultsa . | RoB . |
---|---|---|---|---|---|
Allazzam, 201456 | Unknown | Unknown | EAPD for Judgement MIH | 4.822 (1.196–16.588) | Low |
Arrow, 200957 | Unknown | Unknown | DDE | 0.761 (0.462–1.271) | Low |
Hysi, 201658 | Unknown | Unknown | MIH | 1.41 (1.06–1.87) | Low |
Jälevik, 200164 | Unknown | Unknown | Modified DDE | 0.835 (0.640–1.867) | Low |
Whatling, 200861 | 10 mg/kg per day | NA | DDE | 0.61 (0.17–2.22) | Low |
Wuollet, 201662 | Unknown | Unknown | MIH | 1.72 (0.83–3.58) | Low |
Souza, 201263 | Unknown | Unknown | MIH | 0.93 (0.63–1.37) | Moderate |
Kinirons, 19922 | Unknown | Unknown | DMFT | Mean difference: 1.3 (±1.74); study group: 3.5 (±2.46); intervention group: 4.8 (±3.39) | Serious |
Mariri, 200360 | Unknown | Unknown | Caries | P = .057b | Low |
DMFT, mean number of decayed, missing or filled teeth; EAPD, European Association of Paediatric Dentistry; NA, not applicable; RoB, risk of bias.
Where possible odds ratios of the likelihood of having the outcome measure were calculated and presented with 95% confidence interval. In some cases, the mean value of the exposed group compared with the control groups is given with respect to that outcome measure. If no comparison group was present, the number of the exposed group with the outcome is given as a nominal value over the entire exposed population.
Only a P value was reported.
Discussion
To our knowledge, this is the first systematic review to investigate early childhood antibiotics and 3 dental outcomes (caries, enamel defects, and dental staining). We included evidence from 34 studies. Tetracyclines at higher dosages (≥ 20 mg/kg per day) were associated with dental staining; these doses are not currently recommended. There were conflicting results both between early childhood antibiotics and dental caries and between early childhood antibiotic use and MIH.
There was no evidence that newer tetracycline-related formulations (doxycycline, minocycline), nor other antibiotic classes, were associated with adverse dental outcomes. Our findings are in keeping with other systematic reviews of doxycycline that concluded that median treatment durations up to 10 days had negligible effects on tooth staining.18,27,28,65 The change in formulation from tetracycline to doxycycline included removal of the hydroxyl group at C-6.66 This resulted in an inherent change on calcium binding capacity (doxycycline 19% vs tetracycline 39.5%) with doxycycline, therefore, less likely to result in the ion complexes that cause intrinsic staining.27 This change combined with more recent studies on safety of doxycycline has also prompted the American Academy of Pediatrics 2021 Red Book to recommend use of doxycycline for less than 21 days regardless of age.67
A previous systematic review reported an association between antibiotic use and developmental defects of enamel (MIH) but lacked data on dosage and the age of antibiotic administration, so it was not possible to ascertain if exposure occurred during tooth calcification.68 Notwithstanding, the findings are in keeping with the current study. No studies evaluating enamel defects have determined if the effect on dentition is because of the antibiotic itself or the underlying illness.57,69–71 Therefore, until any risk of MIH has been quantified through prospective studies with data on any dose response relationship, the treatment of infections with antibiotics outweighs any putative MIH risk.
We were unable to draw clear conclusions regarding the effect of early childhood antibiotics on dental caries because of the heterogeneity of outcome measures. Previous studies have reported an increase in risk of dental caries from early childhood antibiotic use.3 This is in contrast to data from patients with cystic fibrosis, who have prolonged cumulative antibiotic exposure from early childhood and in whom there is a lower risk of dental caries.2,5,6
Strengths and Limitations
This study has a number of strengths, including assessment of 3 different dental outcomes for the first time. Two bias tools were used to assess all papers, which was done in duplicate using a number of databases and at several time points. Most of the studies in this systematic review have methodological limitations. All studies rely on retrospective data, and several did not adjust for potential confounders, such as socioeconomic status and age. The previous data on tetracycline-derived antibiotics and dental staining is largely from the 1960s and 1970s, and data quality is limited. The introduction of standardized reporting guidelines (such as STROBE) has improved the quality and reduced bias.72
Limitations include the lack of standardized and validated outcome measures (for tooth staining in particular) that made comparison between studies difficult. Although validated outcome measures were used for both developmental defects of enamel and caries, several different indices were used (Supplemental Table 6). A validated index for tetracycline staining is hard to develop because of the low prevalence of staining. This systematic review applied causal inference using observational data to evaluate the effect of early childhood antibiotic use on dental outcomes. Such analyses are powerful and increasingly common; there are inherent biases and challenges to answering causal questions from observational research.73 General associations between any exposures to antibiotics and dental health without specific doses may provide a signal of an association but are limited in providing causal insights. Further studies with prospective longitudinal cohorts of patients with quantification of dosages would provide more complete evidence to inform clinical practice.
Conclusions
Despite the limitations of the existing, largely retrospective data, we found no evidence that currently used antibiotics at currently recommended doses before 8 years of age was associated with later dental effects of tooth staining, developmental defects of enamel, or caries. Newer formulation tetracyclines (doxycycline and minocycline) at currently recommended doses do not cause long term dental effects. There is conflicting evidence for the relationship between antibiotic use and other dental outcomes (caries and enamel defects). Further well-designed prospective longitudinal cohort studies are needed to determine this relationship using standardized outcomes with adjustment for confounders, together with biological sampling and microbiome analysis, are warranted.
Drs Burgner and Gwee conceptualized and designed the study; Dr Silva conceptualized and designed the study and coordinated and supervised data collection; Dr Ravindra conceptualized and designed the study, designed the data collection instruments, collected data, conducted the initial analyses, and drafted the initial manuscript; Dr Huang collected data and conducted the initial analyses; and all authors critically reviewed and revised the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.
FUNDING: No external funding.
CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.
Comments